US 11918660
Viral vectors for cancer therapy
granted A61KA61K35/763A61K38/193
Quick answer
US patent 11918660 (Viral vectors for cancer therapy) held by Krystal Biotech, Inc. expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Krystal Biotech, Inc.
- Grant date
- Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K35/763, A61K38/193, A61K38/2013, A61K38/208